{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:12:53Z","timestamp":1773979973718,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health;","doi-asserted-by":"publisher","award":["R43AI098290"],"award-info":[{"award-number":["R43AI098290"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.antiviral.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T17:38:51Z","timestamp":1461951531000},"page":"100-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice"],"prefix":"10.1016","volume":"131","author":[{"given":"Sean A.","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"VandenEkart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Roque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Van Hoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.04.001_bib1","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.molimm.2008.05.022","article-title":"Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains","volume":"45","author":"Abhinandan","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/978-1-61779-842-9_32","article-title":"IMGT((R)) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT\/V-QUEST and IMGT\/HighV-QUEST for NGS","volume":"882","author":"Alamyar","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib3","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.1103484","article-title":"Skewed primary Igkappa repertoire and V-J joining in C57BL\/6 mice: implications for recombination accessibility and receptor editing","volume":"188","author":"Aoki-Ota","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib4","doi-asserted-by":"crossref","first-page":"e1004103","DOI":"10.1371\/journal.ppat.1004103","article-title":"Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses","volume":"10","author":"Avnir","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.04.001_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1743-422X-6-224","article-title":"Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein","volume":"6","author":"Beerli","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2016.04.001_bib6","doi-asserted-by":"crossref","first-page":"e80034","DOI":"10.1371\/journal.pone.0080034","article-title":"Mechanisms of hemagglutinin targeted influenza virus neutralization","volume":"8","author":"Brandenburg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.04.001_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/eji.201242563","article-title":"Impact of preexisting memory to seasonal A\/H1N1 influenza virus on the immune response following vaccination against avian A\/H5N1 virus","volume":"43","author":"Buricchi","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/nyas.12012","article-title":"Cross-reactive humoral responses to influenza and their implications for a universal vaccine","volume":"1283","author":"Chiu","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.04.001_bib9","doi-asserted-by":"crossref","first-page":"17585","DOI":"10.1073\/pnas.1207308109","article-title":"Adjuvant solution for pandemic influenza vaccine production","volume":"109","author":"Clegg","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.04.001_bib10","doi-asserted-by":"crossref","first-page":"e88979","DOI":"10.1371\/journal.pone.0088979","article-title":"GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza","volume":"9","author":"Clegg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.04.001_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A\u00a0neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.04.001_bib13","series-title":"National Strategy for Pandemic Influenza Implementation Plan","author":"Council","year":"2006"},{"key":"10.1016\/j.antiviral.2016.04.001_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcv.2005.09.002","article-title":"Avian influenza A (H5N1)","volume":"35","author":"de Jong","year":"2006","journal-title":"J.\u00a0Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nm.3743","article-title":"In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire","volume":"21","author":"DeKosky","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.04.001_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","article-title":"Influenza vaccine immunology","volume":"239","author":"Dormitzer","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2016.04.001_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.04.001_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A\u00a0highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.04.001_bib19","doi-asserted-by":"crossref","first-page":"e9106","DOI":"10.1371\/journal.pone.0009106","article-title":"New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets","volume":"5","author":"Friesen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.04.001_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.it.2014.04.005","article-title":"Studying the antibody repertoire after vaccination: practical applications","volume":"35","author":"Galson","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2015.00531","article-title":"In-depth assessment of within-individual and inter-individual variation in the B cell receptor repertoire","volume":"6","author":"Galson","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4419-5632-3_13","article-title":"Influenza vaccines: what do we want and how can we get it?","volume":"780","author":"Geeraedts","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing of the antibody repertoire","volume":"32","author":"Georgiou","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","article-title":"Enzymatic assembly of DNA molecules up to several hundred kilobases","volume":"6","author":"Gibson","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.antiviral.2016.04.001_bib25","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.04.001_bib26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.04.001_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chom.2014.05.013","article-title":"Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements","volume":"16","author":"Jackson","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.04.001_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.coph.2007.06.004","article-title":"Preparing for a possible pandemic: influenza A\/H5N1 vaccine development","volume":"7","author":"Keitel","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib29","series-title":"Concepts and Procedures for Laboratory Based Influenza Surveillance","first-page":"B17","article-title":"Hemagglutination inhibition","author":"Kendal","year":"1982"},{"key":"10.1016\/j.antiviral.2016.04.001_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coi.2013.07.005","article-title":"Correlates of protection against influenza infection in humans\u2013on the path to a universal vaccine?","volume":"25","author":"Li","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.chom.2013.05.008","article-title":"Convergent antibody signatures in human dengue","volume":"13","author":"Parameswaran","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2016.04.001_bib33","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/j.vaccine.2007.01.050","article-title":"Avian and pandemic influenza: an overview","volume":"25","author":"Poland","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.04.001_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nbt.1673","article-title":"Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells","volume":"28","author":"Reddy","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/protein\/gzs060","article-title":"Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining","volume":"25","author":"Saggy","year":"2012","journal-title":"Protein Eng. Des. Sel. PEDS"},{"key":"10.1016\/j.antiviral.2016.04.001_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(06)69340-9","article-title":"H5N1 vaccines: how prepared are we for a pandemic?","volume":"368","author":"Stephenson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.04.001_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.04.001_bib38","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.04.001_bib39","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.04.001_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002135","article-title":"Targeting TLRs expands the antibody repertoire in response to a malaria vaccine","volume":"3","author":"Wiley","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2016.04.001_bib41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/irv.12230","article-title":"Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses","volume":"8","author":"World Health Organization\/World Organisation for Animal, H.F. Agriculture Organization, H.N.E.W.G","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.antiviral.2016.04.001_bib42","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.04.001_bib43","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1073\/pnas.1219320110","article-title":"Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy\/light chains","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.04.001_bib44","doi-asserted-by":"crossref","first-page":"E4088","DOI":"10.1073\/pnas.1306262110","article-title":"De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T01:05:57Z","timestamp":1567818357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":43,"alternative-id":["S0166354216301966"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.04.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}